Gilbert Habib1,2, Patrizio Lancellotti3,4, Paola-Anna Erba5,6, Anita Sadeghpour7, Marwa Meshaal8, Antonia Sambola9, Shumaila Furnaz10, Rodolfo Citro11, Julien Ternacle12, Erwan Donal13, Bernard Cosyns14, Bogdan Popescu15, Bernard Iung16, Bernard Prendergast17, Cécile Laroche18, Pilar Tornos19,20, Michal Pazdernik21, Aldo Maggioni22, Chris P Gale23. 1. Cardiology Department, APHM, La Timone Hospital, Boulevard Jean Moulin, Marseille, France. 2. Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France. 3. Department of Cardiology, Heart Valve Clinic, University of Liège Hospital, GIGA Cardiovascular Sciences, CHU Sart Tilman, Avenue de l'hôpital, n1, ège, Belgium. 4. Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy. 5. Department of Nuclear Medicine, University of Pisa, Pisa, Italy. 6. University of Groningen, University Medical Center Groningen, Medical Imaging Center, Groningen, The Netherlands. 7. Rajaie Cardiovascular Medical and Research Center, Echocardiography Research Center, Iran University of Medical Sciences, Tehran, Iran. 8. Cairo University Hospitals (Kasr Al Ainy Hospitals), Cairo, Egypt. 9. Department of Cardiology University Hospital Vall d'Hebron, Barcelona, Spain. 10. National Institute of Cardiovascular Disease, Karachi, Pakistan. 11. University Hospital San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy. 12. Department of cardiology, SOS Endocardites, Henri Mondor Hospital, Creteil, France. 13. University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, Rennes, France. 14. Centrum voor Hart en Vaatziekten (CHVZ), Unversitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussel, Belgium. 15. Department of Cardiology, University of Medicine and Pharmacy "Carol Davila"-Euroecolab, Emergency Institute of Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Sos. Fundeni 258, Sector 2, Bucharest, Romania. 16. Hopital Bichat, Paris, France. 17. Guy's and St Thomas', London, UK. 18. EURObservational Research programme (EORP), European Society of Cardiology, Sophia-Antipolis, France. 19. Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 20. Universitat Autònoma de Barcelona, Barcelona, Spain. 21. Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic. 22. EURObservational Research Programme, European Society of Cardiology, France ANMCO Research Center, Florence, Italy. 23. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Abstract
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) European Endocarditis (EURO-ENDO) registry aims to study the care and outcomes of patients diagnosed with infective endocarditis (IE) and compare findings with recommendations from the 2015 ESC Clinical Practice Guidelines for the management of IE and data from the 2001 Euro Heart Survey. METHODS AND RESULTS: Patients (n = 3116) aged over 18 years with a diagnosis of IE based on the ESC 2015 IE diagnostic criteria were prospectively identified between 1 January 2016 and 31 March 2018. Individual patient data were collected across 156 centres and 40 countries. The primary endpoint is all-cause mortality in hospital and at 1 year. Secondary endpoints are 1-year morbidity (all-cause hospitalization, any cardiac surgery, and IE relapse), the clinical, epidemiological, microbiological, and therapeutic characteristics of patients, the number and timing of non-invasive imaging techniques, and adherence to recommendations as stated in the 2015 ESC Clinical Practice Guidelines for the management of IE. CONCLUSION: EURO-ENDO is an international registry of care and outcomes of patients hospitalized with IE which will provide insights into the contemporary profile and management of patients with this challenging disease. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) European Endocarditis (EURO-ENDO) registry aims to study the care and outcomes of patients diagnosed with infective endocarditis (IE) and compare findings with recommendations from the 2015 ESC Clinical Practice Guidelines for the management of IE and data from the 2001 Euro Heart Survey. METHODS AND RESULTS:Patients (n = 3116) aged over 18 years with a diagnosis of IE based on the ESC 2015 IE diagnostic criteria were prospectively identified between 1 January 2016 and 31 March 2018. Individual patient data were collected across 156 centres and 40 countries. The primary endpoint is all-cause mortality in hospital and at 1 year. Secondary endpoints are 1-year morbidity (all-cause hospitalization, any cardiac surgery, and IE relapse), the clinical, epidemiological, microbiological, and therapeutic characteristics of patients, the number and timing of non-invasive imaging techniques, and adherence to recommendations as stated in the 2015 ESC Clinical Practice Guidelines for the management of IE. CONCLUSION:EURO-ENDO is an international registry of care and outcomes of patients hospitalized with IE which will provide insights into the contemporary profile and management of patients with this challenging disease. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Ralf Zahn; Philippe M Barth; Caroline Kilkowski; Boris Fraiture; Ann-Katrin Karcher; René Brütsch; Ralph Winkler; Thomas Kleemann; Steffen Schneider; Dorothee Sutor; Udo Weisse; Falk-Udo Sack Journal: Int J Cardiol Heart Vasc Date: 2021-02-22
Authors: Silvia Corcione; Tommaso Lupia; Carlo Pallotto; Daniele Roberto Giacobbe; Ilaria De Benedetto; Giacomo Stroffolini; Simone Mornese Pinna; Carlo Tascini; Matteo Bassetti; Francesco Giuseppe De Rosa Journal: Antibiotics (Basel) Date: 2022-01-02